Kamada (KMDA) Revenue (2012 - 2026)
Kamada (KMDA) reported Revenue of $45.2 million for Q1 2026, up 2.78% on a YoY basis from $44.0 million in Q1 2025, and up 1.26% quarter-over-quarter from $44.7 million in Q4 2025.
Kamada (KMDA) Revenue (2012 - 2026) Analysis & Trends
Kamada has reported Revenue for 15 years, with the latest figure at $45.2 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 2.78% year-over-year to $45.2 million; the trailing twelve-month figure through Mar 2026 stood at $44.9 billion (up 5.39% YoY), and the FY2025 full-year result was $180.5 million, up 12.12% from the prior year.
- Revenue for Q1 2026 stood at $45.2 million, up from $44.7 million in the prior quarter.
- The five-year high for Revenue was $44.8 billion in Q2 2025, with the low at $23.6 million in Q2 2022.
- Historically, Revenue has averaged $8.9 billion across 5 years, with a median of $44.0 million in 2025.
- Annual changes were most pronounced in 2022 — Revenue surged 139767.15% — and 2023, when it tumbled 99.88%.
- Kamada's Revenue stood at $45.4 million in 2022, then decreased by 19.82% to $36.4 million in 2023, then increased by 7.06% to $39.0 million in 2024, then climbed by 14.54% to $44.7 million in 2025, then increased by 1.26% to $45.2 million in 2026.
- The last three Revenue figures came in at $45.2 million (Q1 2026), $44.7 million (Q4 2025), and $47.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Kamada | 505.05 | -73.15 Mn | 19.12 Mn | 45.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.24 Mn |
| Dec 31, 2025 | 44.68 Mn |
| Sep 30, 2025 | 47.01 Mn |
| Jun 30, 2025 | 44.75 Bn |
| Mar 31, 2025 | 44.02 Mn |
| Dec 31, 2024 | 39.01 Mn |
| Sep 30, 2024 | 41.74 Mn |
| Jun 30, 2024 | 42.47 Bn |
| Mar 31, 2024 | 37.74 Mn |
| Dec 31, 2023 | 36.43 Mn |
| Sep 30, 2023 | 37.93 Mn |
| Jun 30, 2023 | 37.44 Mn |
| Mar 31, 2023 | 30.71 Bn |
| Dec 31, 2022 | 45.44 Mn |
| Sep 30, 2022 | 32.22 Bn |
| Jun 30, 2022 | 23.59 Mn |
| Mar 31, 2022 | 28.09 Mn |
| Dec 31, 2021 | 31.47 Mn |
| Sep 30, 2021 | 23.03 Mn |
| Jun 30, 2021 | 24.24 Mn |